BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 81 filers reported holding BELLICUM PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $6,000 | +20.0% | 4,750 | 0.0% | 0.00% | – |
| Q3 2019 | $5,000 | -37.5% | 4,750 | +9.2% | 0.00% | – |
| Q2 2019 | $8,000 | -50.0% | 4,350 | -11.0% | 0.00% | – |
| Q1 2019 | $16,000 | +23.1% | 4,890 | +12.4% | 0.00% | – |
| Q4 2018 | $13,000 | -74.0% | 4,350 | -46.6% | 0.00% | -100.0% |
| Q3 2018 | $50,000 | -45.7% | 8,150 | -35.1% | 0.00% | 0.0% |
| Q2 2018 | $92,000 | +104.4% | 12,549 | +84.5% | 0.00% | 0.0% |
| Q1 2018 | $45,000 | -8.2% | 6,800 | +15.3% | 0.00% | 0.0% |
| Q4 2017 | $49,000 | +145.0% | 5,900 | +257.6% | 0.00% | – |
| Q3 2017 | $20,000 | +33.3% | 1,650 | +27.7% | 0.00% | – |
| Q2 2017 | $15,000 | 0.0% | 1,292 | +1.5% | 0.00% | – |
| Q1 2017 | $15,000 | +7.1% | 1,273 | +27.3% | 0.00% | – |
| Q4 2016 | $14,000 | -30.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2016 | $20,000 | +66.7% | 1,000 | 0.0% | 0.00% | – |
| Q2 2016 | $12,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|